Temporal Dynamics of Subclinical Malaria in Different Transmission Zones of Myanmar.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
25 Jul 2022
Historique:
received: 12 01 2022
accepted: 19 05 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: aheadofprint

Résumé

Countries in the Greater Mekong Subregion have committed to eliminate Plasmodium falciparum malaria by 2025. Subclinical malaria infections that can be detected by highly sensitive polymerase chain reaction (PCR) testing in asymptomatic individuals represent a potential impediment to this goal, although the extent to which these low-density infections contribute to transmission is unclear. To understand the temporal dynamics of subclinical malaria in this setting, a cohort of 2,705 participants from three epidemiologically distinct regions of Myanmar was screened for subclinical P. falciparum and P. vivax infection using ultrasensitive PCR (usPCR). Standard rapid diagnostic tests (RDTs) for P. falciparum were also performed. Individuals who tested positive for malaria by usPCR were followed for up to 12 weeks. Regression analysis was performed to estimate whether the baseline prevalence of infection and the count of repeated positive tests were associated with demographic, behavioral, and clinical factors. At enrollment, the prevalence of subclinical malaria infection measured by usPCR was 7.7% (1.5% P. falciparum monoinfection, 0.3% mixed P. falciparum and P. vivax, and 6.0% P. vivax monoinfection), while P. falciparum prevalence measured by RDT was just 0.2%. Prevalence varied by geography and was higher among older people and in those with outdoor exposure and travel. No difference was observed in either the prevalence or count of subclinical infection by time of year, indicating that even in low-endemicity areas, a reservoir of subclinical infection persists year-round. If low-density infections are shown to represent a significant source of transmission, identification of high-risk groups and locations may aid elimination efforts.

Identifiants

pubmed: 35895341
doi: 10.4269/ajtmh.22-0027
pii: tpmd220027
pmc: PMC9490656
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Trop Med Hyg. 2017 Nov;97(5):1524-1531
pubmed: 29016341
J Clin Microbiol. 2014 Sep;52(9):3303-9
pubmed: 24989601
Contemp Clin Trials. 2012 Sep;33(5):869-80
pubmed: 22627076
Malar J. 2015 Dec 23;14:520
pubmed: 26701778
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Geohealth. 2020 Dec 01;4(12):e2020GH000299
pubmed: 33364532
Malar J. 2017 Jan 31;16(1):56
pubmed: 28143518
J Infect Dis. 2009 Nov 15;200(10):1509-17
pubmed: 19848588
Am J Trop Med Hyg. 2021 Feb 08;104(4):1371-1374
pubmed: 33556035
Malar J. 2017 Sep 18;16(1):377
pubmed: 28923054
Lancet Infect Dis. 2018 May;18(5):565-572
pubmed: 29398388
PLoS One. 2011;6(6):e20805
pubmed: 21695129
Malar J. 2015 Sep 30;14:381
pubmed: 26424000
PLoS Med. 2016 Jan 19;13(1):e1001942
pubmed: 26783752
Nat Commun. 2012;3:1237
pubmed: 23212366
J Infect Dis. 2019 Apr 16;219(9):1499-1509
pubmed: 30500927
Heliyon. 2017 Nov 20;3(11):e00447
pubmed: 29202107
Malar J. 2017 Apr 4;16(1):138
pubmed: 28376883
Malar J. 2019 Jun 11;18(1):192
pubmed: 31185976
BMC Med. 2020 Jan 28;18(1):9
pubmed: 31987052

Auteurs

Joseph R Egger (JR)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Kay T Han (KT)

Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.

Huang Fang (H)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.

Xiao Nong Zhou (XN)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.

Tin M Hlaing (TM)

Defense Services Medical Research Center, Nay Pyi Taw, Myanmar.

Myo Thant (M)

Defense Services Medical Research Center, Nay Pyi Taw, Myanmar.

Zay Y Han (ZY)

Duke Global Health Institute, Duke University, Durham, North Carolina.
Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar.

Xiao X Wang (XX)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.

Tu Hong (T)

National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.

Alyssa Platt (A)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Ryan Simmons (R)

Duke Global Health Institute, Duke University, Durham, North Carolina.
PPD, Morrisville, North Carolina.

Thynn K Thane (TK)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Manfred Meng (M)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Joyce Hogue (J)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Christine F Markwalter (CF)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Aung Thi (A)

National Malaria Control Program, Myanmar Ministry of Health and Sports, Nay Pyi Taw, Myanmar.

Thura Htay (T)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Zaw W Thein (ZW)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Aye K Paing (AK)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Zin M Tun (ZM)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Swai M Oo (SM)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Poe P Aung (PP)

Duke Global Health Institute, Duke University, Durham, North Carolina.

Myaing M Nyunt (MM)

University of Maryland School of Medicine, Baltimore, Maryland.

Christopher V Plowe (CV)

University of Maryland School of Medicine, Baltimore, Maryland.

Classifications MeSH